Major Depression and Long-Term Survival of Patients with Heart Failure

Psychosomatic Medicine

Volumn 78, Issue 8, 2016, Pages 896-903

  Freedland, Kenneth E ^a   Hesseler, Michael J ^a   Carney, Robert M ^a   Steinmeyer, Brian C ^a   Skala, Judith A ^b   Dávila Román, Victor G ^a   Rich, Michael W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

depression; depressive disorder; heart failure; mortality; survival analysis

Indexed keywords

AFRICAN AMERICAN; AGED; ARTICLE; CAUCASIAN; COHORT ANALYSIS; DEPRESSION; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL PATIENT; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDIAN SURVIVAL TIME; MEDICAL RECORD REVIEW; MORTALITY; MORTALITY RISK; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SURVIVAL ANALYSIS; COMORBIDITY; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COMORBIDITY; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED;

EID: 84969242862     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0000000000000346     Document Type: Article

References (40)

1. Freedland KE, Rich MW, Skala JA, Carney RM, Davila-Roman VG, Jaffe AS. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med 2003;65:119-28.
2. Rutledge T, Reis VA, Linke SE, Greenberg BH,Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006;48:1527-37.
3. American Psychiatric Association, American Psychiatric Association, Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). 4th ed., text revision ed. Washington, DC: American Psychiatric Association; 2000.
4. XiongGL, PrybolK, Boyle SH, Hall R, Streilein RD, Steffens DC, Krishnan R, Rogers JG, O'Connor CM, JiangW. Inflammation markers and major depressive disorder in patients with chronic heart failure: results from the Sertraline Against Depression and Heart Disease in Chronic Heart Failure Study. Psychosom Med 2015;77:808-15.
5. Mommersteeg PM, Schoemaker RG, Eisel UL, Garrelds IM, Schalkwijk CG, Kop WJ. Nitric oxide dysregulation in patients with heart failure: the association of depressive symptoms with L-arginine, asymmetric dimethylarginine, symmetric dimethylarginine, and isoprostane. Psychosom Med 2015; 77:292-302.
6. Redwine LS, Hong S, Rutledge T, Wentworth B, Pung M, Ziegler MG, Maisel A, Greenberg B, Mills PJ. Leukocyte ss-adrenergic receptor sensitivity and depression severity in patients with heart failure. Psychosom Med 2014;76:726-31.
7. Almeida OP, Garrido GJ, Etherton-Beer C, Lautenschlager NT, Arnolda L,Alfonso H, Flicker L. Brain andmood changes over 2 years in healthy controls and adults with heart failure and ischaemic heart disease. Eur J Heart Fail 2013;15:850-8.
8. Albert NM, Fonarow GC, Abraham WT, Gheorghiade M, Greenberg BH, Nunez E, O'Connor CM, Stough WG, Yancy CW, Young JB. Depression and clinical outcomes in heart failure: an OPTIMIZE-HF analysis. Am J Med 2009; 122:366-73.
9. Frasure-Smith N, Lesperance F, Habra M, Talajic M, Khairy P, Dorian P, Roy D. Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation 2009;120:134-40.
10. Jiang W, Kuchibhatla M, Cuffe MS, Christopher EJ, Alexander JD, Clary GL, Blazing MA, Gaulden LH, Califf RM, Krishnan RR, O'Connor CM. Prognostic value of anxiety and depression in patients with chronic heart failure. Circulation 2004;110:3452-6.
11. Jiang W, Kuchibhatla M, Clary GL, Cuffe MS, Christopher EJ, Alexander JD, Califf RM, Krishnan RR, O'Connor CM. Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J 2007; 154:102-8.
12. O'Connor CM, Jiang W, Kuchibhatla M, Mehta RH, Clary GL, Cuffe MS, Christopher EJ, Alexander JD, Califf RM, Krishnan RR. Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med 2008;168: 2232-7.
13. Hwang B, Moser DK, Pelter MM, Nesbitt TS, Dracup K. Changes in depressive symptoms and mortality in patients with heart failure: effects of cognitive-affective and somatic symptoms. Psychosom Med 2015;77:798-807.
14. Johansson P, Dahlstrom U, Alehagen U. Depressive symptoms and six-year cardiovascular mortality in elderly patients with and without heart failure. Scand Cardiovasc J 2007;41:299-307.
15. Chung ML, Dekker RL, Lennie TA, Moser DK. Antidepressants do not improve event-free survival in patients with heart failure when depressive symptoms remain. Heart Lung 2013;42:85-91.
16. Rumsfeld JS, Jones PG, Whooley MA, Sullivan MD, Pitt B, Weintraub WS, Spertus JA. Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure. Am Heart J 2005;150:961-7.
17. Sherwood A, Blumenthal JA, Trivedi R, Johnson KS, O'Connor CM, Adams KF Jr., Dupree CS, Waugh RA, Bensimhon DR, Gaulden L, Christenson RH, Koch GG, Hinderliter AL. Relationship of depression to death or hospitalization in patients with heart failure. Arch InternMed 2007; 167:367-73.
18. Fan H, Yu W, Zhang Q, Cao H, Li J, Wang J, Shao Y, Hu X. Depression after heart failure and risk of cardiovascular and all-cause mortality: a meta-analysis. Prev Med 2014;63:36-42.
19. Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: National Heart, Lung, and Blood Institute; 2012.
20. Carney RM, RichMW, Tevelde A, Saini J, Clark K, Jaffe AS. Major depressive disorder in coronary artery disease. Am J Cardiol 1987;60:1273-5.
21. Cowburn PJ, Cleland JG, Coats AJ, Komajda M. Risk stratification in chronic heart failure. Eur Heart J 1998;19:696-710.
22. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003;290:2581-7.
23. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006;113:1424-33.
24. O'Connor CM, AbrahamWT, Albert NM, Clare R, Gattis SW, Gheorghiade M, Greenberg BH, Yancy CW, Young JB, Fonarow GC. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 2008;156:662-73.
25. O'Connor CM, Whellan DJ, Wojdyla D, Leifer E, Clare RM, Ellis SJ, Fine LJ, Fleg JL, Zannad F, Keteyian SJ, Kitzman DW, Kraus WE, Rendall D, Pina IL, Cooper LS, Fiuzat M, Lee KL. Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: theHF-ACTION predictive risk score model. Circ Heart Fail 2012;5:63-71.
26. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, Ostergren J, Michelson EL, Pieper KS, Granger CB. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006;27:65-75.
27. Lesman-Leegte I, Jaarsma T, Sanderman R, Hillege HL, van Veldhuisen DJ. Determinants of depressive symptoms in hospitalised men and women with heart failure. Eur J Cardiovasc Nurs 2008;7:121-6.
28. Faller H, Stork S, Schowalter M, Steinbuchel T,Wollner V, Ertl G, Angermann CE. Depression and survival in chronic heart failure: does gender play a role? Eur J Heart Fail 2007;9:1018-23.
29. Diez-Quevedo C, Lupon J, Gonzalez B, Urrutia A, Cano L, Cabanes R, Altimir S, Coll R, Pascual T, de Antonio M, Bayes-Genis A. Depression, antidepressants, and long-term mortality in heart failure. Int J Cardiol 2013;167:1217-25.
30. Adams J, Kuchibhatla M, Christopher EJ, Alexander JD, Clary GL, Cuffe MS, Califf RM, Krishnan RR, O'Connor CM, Jiang W. Association of depression and survival in patients with chronic heart failure over 12 years. Psychosomatics 2012;53:339-46.
31. Cuijpers P, Smit F. Subthreshold depression as a risk indicator formajor depressive disorder: a systematic review of prospective studies. Acta Psychiatr Scand 2004;109:325-31.
32. Fosbol EL, Gislason GH, Poulsen HE, Hansen ML, Folke F, Schramm TK, Olesen JB, Bretler DM, Abildstrom SZ, Sorensen R, Hvelplund A, Kober L, Torp-Pedersen C. Prognosis in heart failure and the value of {beta}-blockers are altered by the use of antidepressants and depend on the type of antidepressants used. Circ Heart Fail 2009;2:582-90.
33. O'Connor CM, JiangW, KuchibhatlaM, Silva SG, Cuffe MS, Callwood DD, Zakhary B, StoughWG, Arias RM, Rivelli SK, Krishnan R. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 2010;56:692-9.
34. Kop WJ, Synowski SJ, Gottlieb SS. Depression in heart failure: biobehavioral mechanisms. Heart Fail Clin 2011;7: 23-38.
35. Angermann CE, Gelbrich G, Stork S, Fallgatter A, Deckert J, Faller H, Ertl G. Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF). Eur J Heart Fail 2007;9:1212-22.
36. Pellicori P, Clark AL. Clinical trials update fromthe European Society of Cardiology-Heart Failure meeting 2015: AUGMENTHF, TITRATION, STOP-HF, HARMONIZE, LION HEART, MOOD-HF, and renin-angiotensin inhibitors in patients with heart and renal failure. Eur J Heart Fail 2015;17:979-83.
37. Freedland KE, Carney RM, RichMW, Steinmeyer BC, Rubin EH. Cognitive behavior therapy for depression and self-care in heart failure patients: a randomized clinical trial. JAMA Intern Med 2015;175:1773-82.
38. Gaggin HK, Januzzi JL Jr. Biomarkers and diagnostics in heart failure. Biochim Biophys Acta 2013;1832:2442-50.
39. Kociol RD, Horton JR, Fonarow GC, Reyes EM, Shaw LK, O'Connor CM, Felker GM, Hernandez AF. Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data fromOrganized Programto Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims. Circ Heart Fail 2011;4:628-36.
40. Garfield LD, Scherrer JF, Hauptman PJ, Freedland KE, Chrusciel T, Balasubramanian S, Carney RM, Newcomer JW, Owen R, Bucholz KK, Lustman PJ. Association of anxiety disorders and depression with incident heart failure. Psychosom Med 2014;76:128-36.